---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-024067"
form_type: "8-K"
ticker: "CJMB"
cik: "0002032545"
company_name: "CALLAN JMB INC."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:38:05.789460+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Callan JMB Q2 revenue $1.7M, operating loss $1.4M; forms Revival partnership, secures $25M equity line

## Summary
- Q2 2025 revenue $1.7M, down YoY; H1 revenue $3.1M; gross profit $0.6M and $1.3M respectively.
- Operating loss of $1.4M (Q2) and $2.6M (H1); SG&A rose to $2.0M in Q2 on public-company and hiring costs.
- Cash $4.2M at June 30; post-quarter equity line for up to $25M of common stock.
- Strategic partnership with Revival Health; launched Indian subsidiary with temperature-controlled warehouse.
- Extended Chicago emergency contract to June 2026 with $1.5M increase, total $9.1M; appointed Christopher Shields as SVP.

## SEC filing metadata
- accession: 0001641172-25-024067
- form_type: 8-K
- ticker: CJMB
- cik: 0002032545
- company_name: CALLAN JMB INC.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2032545/000164117225024067/0001641172-25-024067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2032545/000164117225024067/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-024067
- JSON: https://secwatch.observer/filing/0001641172-25-024067.json
- Plain text: https://secwatch.observer/filing/0001641172-25-024067.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.